drugset / Trial / NCT04383717
Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
The use of both levamisole \& Isoprinosine has both synergistic and complementary effect in the treatment of COVID 19 infection
Timeline
- Start
- 2020-05-05
- Primary completion
- 2020-08-30
- Completion
- 2020-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 500 mg | Oral |
| Comparator | Hydroxychloroquine | Small molecule | 200 mg | Oral |
| Comparator | Inosine pranobex | Unknown | 1 g | Oral |
| Comparator | Levamisole | Small molecule | 50 mg | Oral |